The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Blood pressure abnormal 1
SANDOSTATIN LAR DEPOT Blood prolactin abnormal 1
SANDOSTATIN LAR DEPOT Blood sodium abnormal 1
SANDOSTATIN LAR DEPOT Blood thyroid stimulating hormone decreased 1
SANDOSTATIN LAR DEPOT Blood urea abnormal 1
SANDOSTATIN LAR DEPOT Bone density decreased 1
SANDOSTATIN LAR DEPOT Bone density increased 1
SANDOSTATIN LAR DEPOT Brain oedema 1
SANDOSTATIN LAR DEPOT Breast induration 1
SANDOSTATIN LAR DEPOT Bundle branch block right 1
SANDOSTATIN LAR DEPOT Burn oral cavity 1
SANDOSTATIN LAR DEPOT C-reactive protein increased 1
SANDOSTATIN LAR DEPOT Calcification of muscle 1
SANDOSTATIN LAR DEPOT Cardiac infection 1
SANDOSTATIN LAR DEPOT Carotid artery occlusion 1
SANDOSTATIN LAR DEPOT Cerebral haemangioma 1
SANDOSTATIN LAR DEPOT Cerebral infarction 1
SANDOSTATIN LAR DEPOT Cerebral ischaemia 1
SANDOSTATIN LAR DEPOT Cerebrospinal fistula 1
SANDOSTATIN LAR DEPOT Chest injury 1

Total Records: 2,045     Number of Pages: 103